Scripps New Advances in Inflammatory Bowel Disease 2022 (Course)
40 $
Format : 27 MP4 + 1 PDF files
File Size : 5.32 GB
This conference focuses on new advances in the diagnosis and treatment of inflammatory bowel disease (IBD) including disease complications, special population considerations, and surgical options. National experts will share the latest concepts, clinical trial data, and treatment options for IBD. The target audience includes healthcare professionals involved in the care of patients with IBD. The conference covers various topics such as IBD epidemiology and risk factors, approaches to escalation, managing fertility and pregnancy in IBD, and therapeutic drug monitoring.
Scripps New Advances in Inflammatory Bowel Disease 2022 (Course)
The New Advances in Inflammatory Bowel Disease conference is intended to demonstrate the most recent advances in the diagnosis and treatment of IBD. Other than discussing the complications of disease, special populations, and surgical options, the course will be taught by prominent experts who participate in clinical studies and trials regarding the treatment of Crohn’s disease and ulcerative colitis. The purpose of this conference is to provide physicians with the knowledge and context necessary to incorporate the most recent information into their practices, this will ultimately lead to an improvement in the quality of life of their patients with IBD.
Educational Goals:
Summarize Recent Clinical Trial Information: Participants will have a comprehensive understanding of the most recent clinical trial information regarding the next generation of treatments for intestinal inflammation. This understanding will help them to remain abreast of the rapidly evolving landscape of treatment.
Surgical Approaches to IBD Care: Attendees will learn about various surgical procedures used in the treatment of intestinal disease. This includes discussing surgical procedures that may be beneficial for patients that fail to respond to medical treatments or have complications.
Current and Future Therapies Opportunities: Participating participants will discuss current and potential future therapies for patients with inflammatory bowel disease. This involves investigating new therapies and comprehending their potential for clinical application.
The treatment challenges that healthcare professionals encounter when treating patients with IBD will be discussed in the course. By acknowledging these issues, participants will have a better understanding of how to navigate difficult patient scenarios and provide the most effective care.
Target audience:
The training is intended for a variety of healthcare professionals who take part in the treatment of patients with inflammatory bowel disease, these professionals include:
Gastroenterologists
Nurse Practitioners
Physician’s assistants
Nurses
Internists
ectal Surgeons
Other healthcare professionals who take part in the treatment of patients with IBD (IBD) are also involved in the care of these patients.
By participating in the Scripps New Advances in IBD conference, participants will gain important information and updates regarding the field of IBD, this will help them to provide the greatest degree of care to their patients and address the ongoing issues associated with this complex disease.
Topics:
Approaching Escalation with Confidence- Melissa Ferrari, PA
Assessing Your Patient’s Risk- Christina Ha, MD
Case Presentation- Managing Clostridium Difficile Infection in IBD- Mazer Ally, MD
Case Presentation- Managing Your IBD Patient with a History of Cancer- Siddharth Singh, MD
Case Presentation- Updates on COVID-19 & IBD- Brigid Boland, MD
Cases in Perianal Disease- Samuel Eisenstein, MD
Cases in Pouches and Ostomies- M. Jonathan Worsey, MD
Diet and Supplements- Lori Beeken, MS, RD
Dietary Therapies for IB- Gauree Gupta Konijeti, MD, MPH
Getting IBD Drugs Approved- Natalie Whitmire, PharmD
IBD Crash Course & Clinical Pearls- Angelina Collins, NP
IBD Epidemiology and Risk Factors- Frank Scott, MD
Inflammatory Bowel Disease Therapies- Mazer Ally, MD
Inflammatory Bowel Disease- 101- Suresh Pola, MD
Managing Fertility and Pregnancy in IBD- Rebecca Matro, MD
Panel Discussion_Q&A- Angelina Collins, NP, Melissa Ferrari, PA
Panel Discussion_Q&A- Christina Ha, MD, Gauree Gupta Konijeti, MD, MPH, Gil Melmed, MD
Panel Discussion_Q&A- John Chang, MD, Christina Ha, MD, Frank Scott, MD
Panel Discussion_Q&A- Mazer Ally, MD, Brigid Boland, MD, Siddharth Singh, MD
Panel Discussion_Q&A- Samuel Eisenstein, MD, Rebecca Matro, MD, M. Jonathan Worsey, MD
Positioning Therapy for Moderate-Severe Crohn’s Disease- Frank Scott, MD
Positioning Therapy for Moderate-Severe Ulcerative Colitis- Siddharth Singh, MD
Preventive Health in IBD- Brigid Boland, MD
Therapeutic Drug Monitoring- Christina Ha, MD
Treat to Target in IBD- Gil Melmed, MD
Treatment Updates in IBD- Gil Melmed, MD
Update in Mechanisms of IBD Therapy- John Chang, MD
Related Products
